BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28273972)

  • 1. Role of CD10 Immunoexpression in Grading Phyllodes Tumour of the Breast.
    Kulkarni MM; Khandeparkar SG; Joshi AR; Kothikar V; Nasare A; Patil S; Niraspatil S; Dhande B
    J Clin Diagn Res; 2017 Jan; 11(1):EC14-EC16. PubMed ID: 28273972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade.
    Shubham S; Ahuja A; Bhardwaj M
    J Lab Physicians; 2019; 11(4):330-334. PubMed ID: 31929699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
    Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
    Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
    Tan BY; Fox SB; Lakhani SR; Tan PH
    Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
    Puri V; Jain M; Mahajan G; Pujani M
    J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
    Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
    ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
    Ibrahim WS
    Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
    Umekita Y; Yoshida H
    Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between CD10 expression and phyllodes tumor: A retrospective case control study.
    Tian F; Zhao J; Shi QF; Zhang DC; Wang YY; Sun JP; Wang Y; Yang SA; Zhang C
    Medicine (Baltimore); 2023 Nov; 102(44):e35677. PubMed ID: 37933030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
    Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
    Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
    Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
    J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
    Tummidi S; Kothari K; Agnihotri M; Naik L; Sood P
    BMC Cancer; 2020 Jul; 20(1):648. PubMed ID: 32660435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases.
    Wang XY; Mahajan H; Dickinson N; Cox C; Byth K; Bayly A; Cahill MA; Pathmanathan N
    Diagn Cytopathol; 2018 Nov; 46(11):927-935. PubMed ID: 30284391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased p53 protein expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
    Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
    Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
    Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.